The YouTube player loads only when you press play (privacy-enhanced mode). Watch on YouTube
GLP-1s, Diabetes & Weight Management
A new weight-loss tablet: Foundayo vs. Wegovy
Foundayo vs Wegovy pill—which oral weight loss medication is right for different patients?
Foundayo (orforglipron) is a new once-daily oral GLP-1 weight loss medication. In this video, I compare Foundayo with oral Wegovy (semaglutide) from a pharmacist's perspective and explain some of the most important differences patients should understand.
We'll cover:
- Foundayo vs Wegovy pill
- Weight-loss results seen in clinical trials
- How these GLP-1 medications work
- Food and dosing requirements
- When and how the tablets are taken
- Common side effects
- Convenience and other practical considerations
- What I would want patients to understand as a pharmacist
One particularly interesting difference is dosing convenience. Foundayo can be taken once daily with or without food, while oral semaglutide has specific administration requirements.
We'll also look at the weight-loss results reported in clinical trials. Keep in mind that results from separate clinical trials should NOT be treated as a direct head-to-head comparison.
If you're considering a GLP-1 weight loss medication—or you're curious about the rapidly growing number of weight loss pills becoming available—this video will help you understand how these options differ.
- Which would matter more to you: greater convenience, weight-loss effectiveness, side effects, or cost?
Leave your answer in the comments.
Description imported automatically from YouTube.




